Showing results (321-330 of 340) with videos related to
Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activationE M Jaffee, R H Hruban, B Biedrzycki, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2026
Combinatorial immunotherapy drives exhaustion in tumor antigen-specific CD8+ T cells within the mouse renal tumor microenvironmentHolly R Stephens, Elizabeth Elkins, Jing Li, et al.Rheumatology (Oxford, England)|September 9, 2004
Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee--the MOVE consensusE Roddy, W Zhang, M Doherty, et al.JAMA Oncology|April 26, 2019
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 TrialQuynh-Nhu Nguyen, Stephen G Chun, Edward Chow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatinRoy S Herbst, Nizar A Mullani, Darren W Davis, et al.Cancer|March 28, 2017
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trialBing Sun, Eric D Brooks, Ritsuko U Komaki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2018
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung CancerZhongxing Liao, J Jack Lee, Ritsuko Komaki, et al.Breast Cancer Research and Treatment|April 9, 2021
Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in IrelandL M McSorley, M Tharmabala, F Al Rahbi, et al.Irish Journal of Medical Science|April 11, 2025
CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in IrelandW J Mullally, A Hassan, N Keegan, et al.Journal of Bone Oncology|December 29, 2018
Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)R E Coleman, M Collinson, W Gregory, et al.Pageof 34